Ngā hua rapu kaituhi

1

IPF clinical trial design and endpoints mā Steven D. Nathan, Keith C. Meyer

I whakaputaina 2014

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation mā Oksana A. Shlobin, Steven D. Nathan

I whakaputaina 2012

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis mā Abhimanyu Chandel, Jean Pastré, S. Valéry, Christopher S. King, Steven D. Nathan

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics mā Andrew F. Shorr, Donald L. Helman, D. B. Davies, Steven D. Nathan

I whakaputaina 2005

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis mā William M. Reichmann, Yanni Yu, Dendy Macaulay, Eric Q. Wu, Steven D. Nathan

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant mā Andrew F. Shorr, Jennifer L. Wainright, Cindy Cors, Christopher J. Lettieri, Steven D. Nathan

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis mā Christopher J. Lettieri, Steven D. Nathan, Robert Browning, Scott D. Barnett, Shahzad Ahmad, Andrew F. Shorr

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

SERIAL MEASURES OF PULMONARY ARTERY PRESSURES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS mā Steven D. Nathan, Shahzad Ahmad, James P. Koch, Scott D. Barnett, Niv Ad, Nelson A. Burton

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Heart rate recovery after six‐minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis mā Jeffrey J. Swigris, Amy L. Olson, Oksana A. Shlobin, Shahzad Ahmad, Kevin K. Brown, Steven D. Nathan

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

The 6-min walk test as a primary end-point in interstitial lung disease mā Sergio Harari, Athol U. Wells, Wim Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis mā Stephanie Shin, Christopher S. King, Nitin Puri, Oksana A. Shlobin, Anne Brown, Shahzad Ahmad, Nargues Weir, Steven D. Nathan

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis mā Mark Fisher, Steven D. Nathan, Christian Hill, J.D. Marshall, F. Dejonckheere, Per-Olof Thuresson, Toby M. Maher

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views mā Toby M. Maher, Jeffrey J. Swigris, Michael Kreuter, Marlies Wijsenbeek, Nicola Cassidy, Lucy Ireland, Judit Axmann, Steven D. Nathan

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease mā Ho Cheol Kim, Abhimanyu Chandel, Christopher S. King, Min Jee Kim, Malek Shawabkeh, Ambalavanan Arunachalam, Rade Tomic, Steven D. Nathan

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis mā Steven D. Nathan, Ashwin Basavaraj, Cristina Reichner, Oksana A. Shlobin, Shahzad Ahmad, Joseph Kiernan, Nelson A. Burton, Scott D. Barnett

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Lung Transplantation for Patients With COVID-19 mā Christopher S. King, Hannah Mannem, Jasleen Kukreja, Shambhu Aryal, Daniel Tang, Jonathan P. Singer, Ankit Bharat, Jürgen Behr, Steven D. Nathan

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD mā Martin Kolb, Stylianos E. Orfanos, Christopher Lambers, Kevin R. Flaherty, Alison Masters, Lisa Lancaster, Adam M. Silverstein, Steven D. Nathan

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD mā Steven D. Nathan, Abhimanyu Chandel, Ya Wang, Jiawei Xu, Lixin Shao, Timothy R. Watkins, Jack Diviney, Christopher S. King, Ling Han

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Inn... mā Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John Scandurra, Paul M. Hassoun, Sylvia Nikkho, Steven D. Nathan

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts mā Varvara Kirillov, Jonathan T. Siler, Mahalakshmi Ramadass, Lingyin Ge, James E. Davis, Geraldine M. Grant, Steven D. Nathan, Gábor Járai, Glenda Trujillo

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Steven D. Nathan

IPF clinical trial design and endpoints mā Steven D. Nathan, Keith C. Meyer

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation mā Oksana A. Shlobin, Steven D. Nathan

Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis mā Abhimanyu Chandel, Jean Pastré, S. Valéry, Christopher S. King, Steven D. Nathan

Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics mā Andrew F. Shorr, Donald L. Helman, D. B. Davies, Steven D. Nathan

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis mā William M. Reichmann, Yanni Yu, Dendy Macaulay, Eric Q. Wu, Steven D. Nathan

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant mā Andrew F. Shorr, Jennifer L. Wainright, Cindy Cors, Christopher J. Lettieri, Steven D. Nathan

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis mā Christopher J. Lettieri, Steven D. Nathan, Robert Browning, Scott D. Barnett, Shahzad Ahmad, Andrew F. Shorr

SERIAL MEASURES OF PULMONARY ARTERY PRESSURES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS mā Steven D. Nathan, Shahzad Ahmad, James P. Koch, Scott D. Barnett, Niv Ad, Nelson A. Burton

Heart rate recovery after six‐minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis mā Jeffrey J. Swigris, Amy L. Olson, Oksana A. Shlobin, Shahzad Ahmad, Kevin K. Brown, Steven D. Nathan

The 6-min walk test as a primary end-point in interstitial lung disease mā Sergio Harari, Athol U. Wells, Wim Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis mā Stephanie Shin, Christopher S. King, Nitin Puri, Oksana A. Shlobin, Anne Brown, Shahzad Ahmad, Nargues Weir, Steven D. Nathan

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis mā Mark Fisher, Steven D. Nathan, Christian Hill, J.D. Marshall, F. Dejonckheere, Per-Olof Thuresson, Toby M. Maher

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views mā Toby M. Maher, Jeffrey J. Swigris, Michael Kreuter, Marlies Wijsenbeek, Nicola Cassidy, Lucy Ireland, Judit Axmann, Steven D. Nathan

Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease mā Ho Cheol Kim, Abhimanyu Chandel, Christopher S. King, Min Jee Kim, Malek Shawabkeh, Ambalavanan Arunachalam, Rade Tomic, Steven D. Nathan

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis mā Steven D. Nathan, Ashwin Basavaraj, Cristina Reichner, Oksana A. Shlobin, Shahzad Ahmad, Joseph Kiernan, Nelson A. Burton, Scott D. Barnett

Lung Transplantation for Patients With COVID-19 mā Christopher S. King, Hannah Mannem, Jasleen Kukreja, Shambhu Aryal, Daniel Tang, Jonathan P. Singer, Ankit Bharat, Jürgen Behr, Steven D. Nathan

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD mā Martin Kolb, Stylianos E. Orfanos, Christopher Lambers, Kevin R. Flaherty, Alison Masters, Lisa Lancaster, Adam M. Silverstein, Steven D. Nathan

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD mā Steven D. Nathan, Abhimanyu Chandel, Ya Wang, Jiawei Xu, Lixin Shao, Timothy R. Watkins, Jack Diviney, Christopher S. King, Ling Han

Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts mā Varvara Kirillov, Jonathan T. Siler, Mahalakshmi Ramadass, Lingyin Ge, James E. Davis, Geraldine M. Grant, Steven D. Nathan, Gábor Járai, Glenda Trujillo

Ngā utauta rapu:

Ngā marau whai pānga